We are live on ! Find out more
MA

MYDA Advisors Portfolio holdings

AUM $608M
1-Year Est. Return 77.08%
This Fund
S&P 500
This Quarter Est. Return
-12.45%
1 Year Est. Return
+77.08%
3 Year Est. Return
+189.24%
5 Year Est. Return
+248.06%
10 Year Est. Return
AUM
$358M
AUM Growth
+$104M
Cap. Flow
+$159M
Cap. Flow %
44.54%
Top 10 Hldgs %
43.47%
Holding
272
New
65
Increased
26
Reduced
44
Closed
71

Sector Composition

Rank Sector Weight
1 Financials 24.48%
2 Consumer Discretionary 11.21%
3 Technology 4.85%
4 Communication Services 4.51%
5 Healthcare 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIAN
151
DELISTED
LianBio American Depositary Shares
LIAN
$259K 0.07%
120,000
+34,000
+40% +$115K
MYPS icon
152
PLAYSTUDIOS Inc
MYPS
$105M
$257K 0.07%
60,000
-40,000
-40% -$217K
BMTX
153
DELISTED
BM Technologies, Inc.
BMTX
$240K 0.07%
40,749
-65,251
-62% -$457K
LTHM
154
DELISTED
Livent Corporation
LTHM
$227K 0.06%
10,000
-25,000
-71% -$643K
TALK icon
155
Talkspace
TALK
$873M
$221K 0.06%
+130,000
New +$195K
BCAB icon
156
BioAtla
BCAB
$6.14M
$211K 0.06%
1,480
+280
+23% +$44.6K
OPEN icon
157
Opendoor
OPEN
$4.29B
$188K 0.05%
+41,333
New +$272K
AFMD
158
DELISTED
Affimed
AFMD
$180K 0.05%
6,500
-500
-7% -$17.1K
ENVX icon
159
Enovix
ENVX
$997M
$178K 0.05%
+22,857
New +$215K
SBDS
160
CALL
DELISTED
Solo Brands Inc
SBDS
$162K 0.05%
+1,000
New +$219K
ORGNW
161
DELISTED
Origin Materials Inc Warrants
ORGNW
$155K 0.04%
153,459
LICY
162
CALL
DELISTED
Li-Cycle Holdings Corp.
LICY
$138K 0.04%
+2,500
New +$146K
CRCT icon
163
Cricut
CRCT
$966M
$123K 0.03%
+20,000
New +$197K
BKSY icon
164
CALL
BlackSky Technology
BKSY
$811M
$119K 0.03%
+6,425
New +$98K
BOXD
165
DELISTED
Boxed, Inc.
BOXD
$111K 0.03%
+60,000
New +$463K
NXDR
166
Nextdoor Holdings
NXDR
$927M
$99K 0.03%
+30,000
New +$118K
STRY.WS
167
DELISTED
Starry Group Holdings, Inc. Warrants, each whole warrant exercisable to purchase 1.2415 shares of Class A common stock at an exercise price of $11.50 per 1.2415 shares of Class A common stock
STRY.WS
$87K 0.02%
210,000
-65,000
-24% -$74.6K
ASLN
168
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$74K 0.02%
3,750
DNTH icon
169
Dianthus Therapeutics
DNTH
$5.52B
$72K 0.02%
+3,750
New +$92.7K
VYGR icon
170
Voyager Therapeutics
VYGR
$184M
$71K 0.02%
+12,000
New +$81.1K
CRDF icon
171
Cardiff Oncology
CRDF
$65.1M
$66K 0.02%
+30,000
New +$50.2K
DBTX
172
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$63K 0.02%
15,000
-5,000
-25% -$11.8K
LUXAW
173
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$51K 0.01%
340,509
OWL.WS
174
DELISTED
Blue Owl Capital Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A C
OWL.WS
$45K 0.01%
21,562
RKDA icon
175
Arcadia Biosciences
RKDA
$1.45M
$40K 0.01%
1,001

Similar funds

MYDA Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, MYDA Advisors held 272 positions worth $358M, up 41% from $253M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

MYDA Advisors deployed $159M of net new capital in Q2 2022, opening 65 new positions and adding to 26 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 67,500 shares worth $18.4M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $4.92M trimmed.

  • MYDA Advisors's largest Q2 2022 buy was Berkshire Hathaway Class B: 67,500 shares worth $18.4M.
  • MYDA Advisors added most to Marriott International in Q2 2022, an estimated $10.5M increase.
  • MYDA Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.92M.
  • MYDA Advisors fully exited Alphabet (Google) Class A in Q2 2022, selling an estimated $4.73M.
  • MYDA Advisors's ten largest holdings make up 43% of its $358M portfolio in Q2 2022.
  • MYDA Advisors opened 65 new positions and closed 71 in Q2 2022.
  • MYDA Advisors's portfolio value rose 41% quarter-over-quarter to $358M.

Based on MYDA Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.